Publicacións en colaboración con investigadores/as de Instituto Ramón y Cajal de Investigación Sanitaria (11)

2022

  1. Cannabinoid CB1 receptor expression in oligodendrocyte progenitors of the hippocampus revealed by the NG2-EYFP-knockin mouse

    Frontiers in Neuroanatomy, Vol. 16

  2. Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice

    Cell Death and Disease, Vol. 13, Núm. 7

2021

  1. Neuropathological Characterization of a Dravet Syndrome Knock-In Mouse Model Useful for Investigating Cannabinoid Treatments

    Frontiers in Molecular Neuroscience, Vol. 13

  2. Δ9-Tetrahydrocannabinol promotes functional remyelination in the mouse brain

    British Journal of Pharmacology, Vol. 178, Núm. 20, pp. 4176-4192

  3. Δ9-Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo

    GLIA, Vol. 69, Núm. 3, pp. 532-545

2020

  1. Glucose metabolism links astroglial mitochondria to cannabinoid effects

    Nature, Vol. 583, Núm. 7817, pp. 603-608

2019

  1. Cannabidiol administration prevents hypoxia-ischemia-induced hypomyelination in newborn rats

    Frontiers in Pharmacology, Vol. 10, Núm. SEP

2018

  1. Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum

    Neuropsychopharmacology, Vol. 43, Núm. 5, pp. 964-977

2014

  1. A restricted population of CB1 cannabinoid receptors with neuroprotective activity

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Núm. 22, pp. 8257-8262

2004

  1. Nitric oxide synthase and NADPH-diaphorase after acute hypobaric hypoxia in the rat caudate putamen

    Experimental Neurology, Vol. 186, Núm. 1, pp. 33-45

2002

  1. Adrenomedullin over-expression in the caudate-putamen of the adult rat brain after ischaemia-reperfusion injury

    Neuroscience Letters, Vol. 329, Núm. 2, pp. 197-200